The Effect of Chocolate Consumption on Cardiovascular Disease Risk Factors Stephanie Becker November 24, 2014.

Slides:



Advertisements
Similar presentations
Scientific writing (81-933) Lecture 5: Discussion Dr. Avraham Samson Faculty of Medicine in the Galilee 1.
Advertisements

K. HERT, M.G. WAGNER, L. MYERS, J. LEVINE*, T. HECK, Y. RHEE HEALTH, NUTRITION, AND EXERCISE SCIENCES, NORTH DAKOTA STATE UNIVERSITY, FARGO, ND, *FAMILY.
Evesse® “... Its why fruit is good for you!” Richard Wood Chief Executive Coressence Limited © Coressence 2007.
The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
Inactive lifestyle. Risk!! Inactive life style = the same risk as hypertension Inactive life style = the same risk as cholesterol Inactive life style.
Blood pressure reduction with statins Meta-analysis of randomised controlled trials P. Strazzullo 1, S.M. Kerry 2, A. Barbato 1,2, M. Versiero 1, L. D’Elia.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
Sugar-Sweetened Beverage Consumption and Incident Cardiovascular Risk Factors: The Multi-Ethnic Study of Atherosclerosis (MESA) Christina Shay PhD MA 1.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.
Journal Club 1 The bigger picture. How we hope it works – Introduction – Discussion Points – Summary.
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
Body Mass Index, Weight Change and Death in an Older Hypertensive Population: The SHEP Study Grant W Somes Stephen B Kritchevsky Marco Pahor Ronald I Shorr.
© Arginine Benefits LLC, 2013Author: Dr. Rainer BögerPage 1 Arginine Cardio: Evidence-based reduction of blood pressure (1) L-Arginine is the precursor.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
Candy: What is Moderate Consumption?
ABSTRACT CONCLUSION RESULTSBACKGROUND Decreased High Density Lipoprotein Cholesterol in a Cohort of 6th-grade Children: Association with Cardiovascular.
Risk factors to the Cardiovascular System. Learning Outcomes Describe modifiable risk factors: diet, smoking, activity, obesity Describe non-modifiable.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Assessment of Radial Pulse Wave Analysis, Insulin Resistance, and Glucose Homeostasis in African Americans at High Risk for Developing Type 2 Diabetes.
Michelle Koford Summer Topics Discussed Background Purpose Research Questions Methods Participants Procedures Instrumentation Analysis.
Conclusion In conclusion, preliminary data from this nutrition intervention study suggest that a well balanced Mediterranean-type diet is able to reduce.
Gabrielle Sherer Cardiovascular Risk Reduction Jeff Luckring MS, RD.
Copyright® Raisio The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins Gylling et.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Calculated LDL by Age Cases vs. Controls Figure 1.
Salt, Heart Disease, and Stroke Norm Campbell. 1) The role of increased blood pressure as a determinant of adverse outcomes 2) The health risks of high.
University of South Florida College of Nursing Tampa, Florida.
Effectiveness of a motivational interviewing intervention on weight loss, physical activity and cardiovascular disease risk factors: a randomized controlled.
Thiazide diuretics, Potassium, and the Development of Diabetes A Quantitative Review Hypertension2006_219.
Cardiovascular Disease (CVD) A general term for diseases of the heart and/or blood __________ _____% of all deaths annually 2,600 American deaths each.
Low Fat Center for Energy Balance Journal Club Shannon Armbruster MD Gynecologic Oncology October 15, 2015.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
Identifying Persons in Need of Weight-loss Treatment: Evaluation of Potential Treatment Algorithms Caitlin Mason School of Physical and Health Education.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan,
Fast fOod Shops Significantly Impact Cardiovascular Karma - the FOSSICK IV Trial - Reddy M, Luque M, Ferrer Ferrer L, Koju R, Zaman MJ, Inspiron D, Caprnda.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
PHYSICAL ACTIVITY IN HEALTH PROFESSION STUDENTS By: Andrea Mahon and Sara Haller.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Exercise and Weight Loss Reduce Blood Pressure in.
Current research suggests that older adults will benefit from increasing their whole grain consumption. An emphasis on whole grain intake is presented.
1 Body-Mass Index and Mortality in Korean Men and Women Sun Ha Jee, Ph.D., Jae Woong Sull, Ph.D., Jung yong Park, Ph.D., Sang-Yi Lee, M.D. From the Department.
Health Psychology Fourth Edition Quiz Chapter 10
CVD Part 2.
A Look at College Students’ Nutritional Knowledge
Preventing Cardiovascular Disease
Prevalence Of Metabolic Syndrome And Assessment Of Nutritional And Biochemical Parameters Of Overweight And Obese Working Women 1Upasana, 2Chakravarty.
BACKGROUND & SIGNIFICANCE
by Sarah Steinmetz and Amber Brouillette
Executive Summary Tyler Masar.
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Associations of Diet and Lifestyle with Hyperlipidemia for the Middle-Aged and Elderly in the Guangxi Bai Ku Yao and Han Populations Yin Ruixing, MD: Guangxi.
The Hypertension in the Very Elderly Trial (HYVET)
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Type 2 diabetes: Overlap of clinical conditions
Section 7: Aggressive vs moderate approach to lipid lowering
OmniHeart Feeding Study
Presentation transcript:

The Effect of Chocolate Consumption on Cardiovascular Disease Risk Factors Stephanie Becker November 24, 2014

Outline Purpose Background Methods Findings Conclusions Implications Future Research Required

Purpose To examine the relationship between chocolate consumption and cardiovascular disease risk.

Cardiovascular Disease (CVD) Leading cause of death for Americans equating to 34% of all deaths. 60,000 Americans die from CVD every year. Every 1 in 4 deaths is CVD related. (Center for Disease Control, 2014)

Cardiovascular Disease Risk Factors Hypertension High LDL-C Low HDL-C Oxidative Stress High BMI Lack of Physical Activity Poor Diet

How Can Chocolate Help? Polyphenols: – A phytochemical found in chocolate thought to be responsible for combating CVD risk factors. – Found in teas and fruit juices as well. Chocolate has been found to have one of the highest polyphenol contents compared to other foods.

Methods Simmons College Library Network – Medline, CINAHAL, Web of Science, Academic Search Complete Keywords – Chocolate OR Cocoa OR Cacao – AND Cardiovascular disease OR Cardiovascular risk factors Techniques – Thesaurus, Boolean operators, Citation Index

Methods Inclusion Criteria: – Published in 2010 or later – Peer Reviewed Academic Journal Exclusion Criteria: – Language other than English – Literature reviews – Animal subjects A total of 15 studies were used for this literature review.

Results Topic# of StudiesDesignAssociation (Yes) Association (No) CVD Risk and CVD Mortality 2(1) Prospective Cohort (1) Cross- Sectional 20 Blood Pressure5(4) Randomized Controlled Trials (1) Longitudinal 50 Serum Cholesterol 3(3) Randomized Controlled Trials 30 Other CVD Risk Factors 8(6) Randomized Controlled Trials (1) Cross- sectional (1) Intervention Clinical Trial 71

Chocolate Consumption, CVD Risk, and CVD Mortality Topic# of StudiesDesignAssociation (Yes) Association (No) Chocolate Consumption, CVD Risk, and CVD Mortality 2(1)Prospective Cohort (1) Cross- Sectional 20 Both studies used food frequency questionnaires to access chocolate intake. The prospective cohort study had a 7 year follow up when the National Death Index was used in order to access mortality. Both studies recruited subjects from previous cohort studies

Chocolate Consumption, CVD Risk, and CVD Mortality Author/DateDesign/# of SubjectsResults Djousse et al., 2011Cross- sectional/ 4,970Those who consumed chocolate had a lower risk of CVD (P trend <0.0001) McCullough et al., 2012Prospective Cohort/98,469Those in the top quartile of flavonoid intake compared to the bottom quartile had a lower risk of fatal CVD (p trend= 0.01)

Strengths and Limitations Strengths: – Large sample sizes – Accurate dietary software – Drop off rate for prospective cohort was only 11% Limitations: – Self-Reporting – Diets not controlled during the follow up period

Chocolate Consumption and Blood Pressure Topic# of StudiesDesignAssociation (Yes) Association (No) Chocolate Consumption and Blood Pressure 5(4) Randomized Controlled Trials (1) Longitudinal 50 All clinical trials provided their own chocolate products The longitudinal study was based on a food frequency questionnaire.

Chocolate Consumption and Blood Pressure Author/DateDesign/# of subjectsResults Almoosawi et al., 2010Randomized cross-over/14SBP and DBP both significantly lower then baseline (SBP: p=0.001, DBP: p=0.001) Almoosawi et al., 2012Randomized cross-over/42SBP reduced in normal weight and overweight group (NW: p=0.014, OW: P=0.016) DBP reduction in overweight group (p<0.001) Bogaard et al., 2010Randomized 3-period cross-over/ High dose theobromine showed a reduction in both SBP and DBP compared to placebo (SBP: P<0.01, DBP: p=0.04)

Chocolate Consumption and Blood Pressure Author/DateDesign/# of SubjectsResults Sudarma et al., 2011Parallel Randomized Clinical Trial/32 Significant difference in SBP in treatment vs. control (p=0.001). No significant difference in DBP (p=0.308) Buijsse et al., 2010Longitudinal/19,357Significant difference in SBP and DBP in the top quartile for chocolate consumption vs. the bottom quartile (SBP: p< , DBP: p=0.014)

Strengths and Limitations Strengths: – Majority of trials used a standard cocoa product – Strict inclusion criteria – Longitudinal study had a large sample size Limitations: – Clinical trials had small sample sizes – All studies were done on people with different CVD risk factors

Chocolate Consumption and Serum Cholesterol Levels Topic#of studiesDesignAssociation (Yes) Association (No) Chocolate Consumption and Serum Cholesterol Levels 3(3) Randomized Controlled Trials 30 All studies provided chocolate products to participants

Chocolate Consumption and Serum Cholesterol Levels Author/DateDesign/# of SubjectsResults Anuzzi, et al., 20102x2 factorial/86A significant reduction was shown in VLDL-C in treatment vs. control (p=0.016) Khan et al., 2011Randomized cross-over/47A significant reduction in LDL-C (p=0.001 and a significant increase in HDL- C (p=0.008) was found in treatment vs. control. Sola et al., 2012Parallel multi-centered/113Reduction in LDL-C and Apo B/Apo A ratio in treatment vs. control (p=0.002, p=0.0085)

Strengths and Limitations Strengths: – Diets were kept uniform in all studies (Sola et al., kept participants on a low saturated fat diet) – Large sample size compared to other clinical trials Limitations: – Short trial periods – Compliance to these specific diets is unknown

Chocolate Consumption and Other CVD Risk Factors Topic# of StudiesDesignAssociation (Yes) Association (No) Chocolate Consumption and Other CVD Risk Factors 8(6) Randomized Controlled Trials (1) Intervention Trial (1) Cross- sectional 71 Various CVD Risk factors were tested including: Nitric Oxide levels, fasting glucose levels, DNA methylation, arterial stiffness, and endothelial function. 3 studies in this section were also used in other sections

Chocolate Consumption and Other CVD Risk Factors Author/DateDesign/# of SubjectsResults Crescenti et al., 2013Randomized Controlled Trial/254 Peripheral leukocyte DNA methylation status was significantly lower in the treatment group vs. control (p< 0.001) Flammer et al., 2011Randomized Controlled Trial/22 No significant results found. West et al., 2013Randomized cross-over/ 30Hyperaemic blood flow increased post treatment (Basal: p=0.04, peak: p=0.03). Augmentation Index at 75bpm was decreased in women post treatment (p=0.01)

Chocolate Consumption and Other CVD Risk Factors Author/DateDesign/# of SubjectsResults Nogeuria et al., 2012Intervention Trial/20Significant increase in endothelial function after intervention (p=0.01) Djousse et al., 2011Cross-Sectional/2,217Increased chocolate consumption decreased calcified atherosclerotic plaque in coronary arteries (p trend= 0.022) Sudarma et al., 2011*Parallel Randomized Clinical Trial/32 Nitric Oxide Serum levels significantly higher in treatment vs. control group (p=0.001) * Represents a study that was also used in a previous section

Chocolate Consumption and Other CVD Risk Factors Author/DateDesign/# of SubjectsResults Almoosawi et al., 2010*Randomized cross-over/14Significant reduction on fasting glucose levels in treatment vs. control group (p=0.026) Almoosawi et al., 2012*Randomized cross-over/42Fasting glucose and HOMA- IR were reduced from baseline in participants with a BMI ≥ 25 kg/m 2 (FG: p<0.001, HOMA-IR: p=0.041)

Strengths and Limitations Strengths: – Multiple risk factored studied to get a broader view on the effect that chocolate has on CVD risk. – Different study designs used. Limitations: – Very few studies were done on each individual risk factor, therefore it is difficult to draw significant conclusions.

Conclusions All studies, with the exception of the study conducted by Flammer et al. showed an association between chocolate consumption and CVD risk. Chocolate consumption reduced systolic blood pressure more significantly then diastolic blood pressure. Polyphenols in chocolate were shown to reduce various CVD risk factors.

Implications Regular consumption of dark chocolate may help to lower CVD risk factors in those individuals who already have a higher then average CVD risk. In order to prevent other CVD risk factors it is recommended to add chocolate to a low saturated fat diet.

Future Research Research needs to be done on healthy subjects without any CVD risks. The exact mechanism of how chocolate lowers CVD risk is unknown. Further research needs to be done on the biological level to find the exact mechanism. There is now a chocolate shortage, how to counteract that?

Thank you for your time! Questions?